Revenue, last year
CAD 946.4M
+2.8% vs prior year
Net income
−CAD 15.8M
+83.4% vs prior year
EPS, diluted
−CAD 0.06
+83.3% vs prior year
Operating cash flow
CAD 70.9M
+29.1% vs prior year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | CAD 946.4M | −CAD 15.8M |
| FY24 | CAD 920.4M | −CAD 94.8M |
| FY23 | CAD 909M | −CAD 172.7M |
| FY22 | CAD 712.2M | −CAD 335.1M |
| FY21 | CAD 56.1M | −CAD 227M |
| FY20 | CAD 60.9M | −CAD 233.2M |
| FY19 | CAD 63.6M | −CAD 271.5M |
| FY18 | - | −CAD 13M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 27.3% | −0.7% | −1.7% |
| FY24 | 26.1% | −11.3% | −10.3% |
| FY23 | 20.9% | −18% | −19% |
| FY22 | 19.7% | −48.8% | −47.1% |
| FY21 | −16% | −239.4% | −404.4% |
| FY20 | −81.9% | −304.4% | −382.9% |
| FY19 | 57.4% | −82.4% | −427.1% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | CAD 58.1M |
| FY24 | CAD 46.3M |
| FY23 | −CAD 24.5M |
| FY22 | −CAD 17.4M |
| FY21 | −CAD 159.5M |
| FY20 | −CAD 60.5M |
| FY19 | −CAD 223M |
| FY18 | −CAD 12.8M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | CAD 15.3M |
| FY24 | CAD 13.2M |
| FY23 | CAD 1.5M |
| FY22 | CAD 13.4M |
| FY21 | CAD 0 |
| FY20 | CAD 0 |
| FY19 | - |
| FY18 | - |
- SNDL
- Healthcare median
Show the numbers
| Year | SNDL | Healthcare median |
|---|---|---|
| FY25 | −1.7% | −30.6% |
| FY24 | −10.3% | −47% |
| FY23 | −19% | −58% |
| FY22 | −47.1% | −80.4% |
| FY21 | −404.4% | −71.8% |
| FY20 | −382.9% | −62.2% |
| FY19 | −427.1% | −46.2% |
| FY18 | - | −49.6% |